United Kingdom· GB-APID-45789011000001107
Rifamazid 150mg/100mg capsules
A rifampicin and isoniazid product containing rifampicin + isoniazid, registered in United Kingdom by Imported (Poland). The same ATC class is registered in 9 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Rifampicin and isoniazid is registered in 9 of 19 countries.
Countries holding a registration under ATC J04AM02 (rifampicin and isoniazid), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Rifampicin and isoniazid · ATC J04AM02
9 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Rifampicin + Isoniazid
- Manufacturer
- Imported (Poland)
- Country
- United Kingdom (GB)
- ATC code
- J04AM02
- ATC class
- Rifampicin and isoniazid
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
61 interactions on record for rifampicin and isoniazid.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rifampicin and isoniazid · interactions on record
61 records
61 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Rifampicin and isoniazid in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayRifinahsanofi-aventis (2)
- SwitzerlandRifinah, comprimés enrobésSanofi-Aventis (Suisse) SA
- IrelandRifinah 150/100 mg Film- Coated TabletsSanofi-Aventis Ireland Limited T/A SANOFI
- NetherlandsRifinah 300 mg/150 mg, filmomhulde tabletSanofi B.V.
- PolandRifamazidTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- CzechiaRIFAMPICIN 75MG + ISONIAZID 50MG
- SwedenRimactazid 150 mg/75 mg Filmdragerad tablettSandoz A/S
- FinlandRimactazidSandoz A/S
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Rifoldin Mit Inh
- Cyprus · Rifamazid
- Denmark · Rimactazid
- Spain · Rifinah
- France · Rifinah
- Greece · Rifinah
- Hungary · Rifazid
- Ireland · Rifinah
- Italy · Rifinah
- Lithuania · Rifamazid
- Netherlands · Rifinah
- Norway · Rimactazid
- Poland · Rifamazid
- Portugal · Rifinah
- Romania · Sinerdol Iso
- Sweden · Rimactazid
- Slovenia · Rifinah
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e14a4534-e320-4b24-b70d-991eba603986 GET /v1/drugs/e14a4534-e320-4b24-b70d-991eba603986?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45789011000001107",
"desc": "Rifamazid 150mg/100mg capsules (Imported (Poland))",
"form": "Oral capsule",
"vpid": "45792411000001108",
"source": "dmd",
"vtm_id": "776414001",
"strength": "100 mg",
"substance": "Rifampicin + Isoniazid",
"ingredient": "Isoniazid",
"supplier_code": "38882011000001109"
}See everything about rifampicin and isoniazid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.